These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 9559339)
1. An FHIT tumor suppressor gene? Le Beau MM; Drabkin H; Glover TW; Gemmill R; Rassool FV; McKeithan TW; Smith DI Genes Chromosomes Cancer; 1998 Apr; 21(4):281-9. PubMed ID: 9559339 [TBL] [Abstract][Full Text] [Related]
2. Precise localization of the FHIT gene to the common fragile site at 3p14.2 (FRA3B) and characterization of homozygous deletions within FRA3B that affect FHIT transcription in tumor cell lines. Ong ST; Fong KM; Bader SA; Minna JD; Le Beau MM; McKeithan TW; Rassool FV Genes Chromosomes Cancer; 1997 Sep; 20(1):16-23. PubMed ID: 9290949 [TBL] [Abstract][Full Text] [Related]
3. Identification of unstable sequences within the common fragile site at 3p14.2: implications for the mechanism of deletions within fragile histidine triad gene/common fragile site at 3p14.2 in tumors. Corbin S; Neilly ME; Espinosa R; Davis EM; McKeithan TW; Le Beau MM Cancer Res; 2002 Jun; 62(12):3477-84. PubMed ID: 12067991 [TBL] [Abstract][Full Text] [Related]
4. The role of the FHIT/FRA3B locus in cancer. Huebner K; Garrison PN; Barnes LD; Croce CM Annu Rev Genet; 1998; 32():7-31. PubMed ID: 9928473 [TBL] [Abstract][Full Text] [Related]
5. FHIT and FRA3B 3p14.2 allele loss are common in lung cancer and preneoplastic bronchial lesions and are associated with cancer-related FHIT cDNA splicing aberrations. Fong KM; Biesterveld EJ; Virmani A; Wistuba I; Sekido Y; Bader SA; Ahmadian M; Ong ST; Rassool FV; Zimmerman PV; Giaccone G; Gazdar AF; Minna JD Cancer Res; 1997 Jun; 57(11):2256-67. PubMed ID: 9187130 [TBL] [Abstract][Full Text] [Related]
6. The murine Fhit gene is highly similar to its human orthologue and maps to a common fragile site region. Glover TW; Hoge AW; Miller DE; Ascara-Wilke JE; Adam AN; Dagenais SL; Wilke CM; Dierick HA; Beer DG Cancer Res; 1998 Aug; 58(15):3409-14. PubMed ID: 9699673 [TBL] [Abstract][Full Text] [Related]
7. FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas. Bugert P; Wilhelm M; Kovacs G Genes Chromosomes Cancer; 1997 Sep; 20(1):9-15. PubMed ID: 9290948 [TBL] [Abstract][Full Text] [Related]
8. The role of deletions at the FRA3B/FHIT locus in carcinogenesis. Huebner K; Druck T; Siprashvili Z; Croce CM; Kovatich A; McCue PA Recent Results Cancer Res; 1998; 154():200-15. PubMed ID: 10027001 [TBL] [Abstract][Full Text] [Related]
9. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene. Zimonjic DB; Druck T; Ohta M; Kastury K; Croce CM; Popescu NC; Huebner K Cancer Res; 1997 Mar; 57(6):1166-70. PubMed ID: 9067288 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the FHIT gene and FRA3B region in sporadic breast cancer, preneoplastic lesions, and familial breast cancer probands. Ahmadian M; Wistuba II; Fong KM; Behrens C; Kodagoda DR; Saboorian MH; Shay J; Tomlinson GE; Blum J; Minna JD; Gazdar AF Cancer Res; 1997 Sep; 57(17):3664-8. PubMed ID: 9288768 [TBL] [Abstract][Full Text] [Related]
11. Induction of the common fragile site FRA3B does not affect FHIT expression. Michael D; Rajewsky MF Oncogene; 2001 Mar; 20(14):1798-801. PubMed ID: 11313927 [TBL] [Abstract][Full Text] [Related]
12. Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic. Matsuyama A; Shiraishi T; Trapasso F; Kuroki T; Alder H; Mori M; Huebner K; Croce CM Proc Natl Acad Sci U S A; 2003 Dec; 100(25):14988-93. PubMed ID: 14630947 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the fragile histidine triad gene in primary gastric carcinomas and gastric carcinoma cell lines. Tamura G; Sakata K; Nishizuka S; Maesawa C; Suzuki Y; Iwaya T; Terashima M; Saito K; Satodate R Genes Chromosomes Cancer; 1997 Sep; 20(1):98-102. PubMed ID: 9290961 [TBL] [Abstract][Full Text] [Related]
14. Chromosome 3p14 homozygous deletions and sequence analysis of FRA3B. Boldog F; Gemmill RM; West J; Robinson M; Robinson L; Li E; Roche J; Todd S; Waggoner B; Lundstrom R; Jacobson J; Mullokandov MR; Klinger H; Drabkin HA Hum Mol Genet; 1997 Feb; 6(2):193-203. PubMed ID: 9063739 [TBL] [Abstract][Full Text] [Related]
15. Translocation breakpoints in FHIT and FRA3B in both homologs of chromosome 3 in an esophageal adenocarcinoma. Fang JM; Arlt MF; Burgess AC; Dagenais SL; Beer DG; Glover TW Genes Chromosomes Cancer; 2001 Mar; 30(3):292-8. PubMed ID: 11170287 [TBL] [Abstract][Full Text] [Related]
16. Frequent homozygous deletions in the FRA3B region in tumor cell lines still leave the FHIT exons intact. Wang L; Darling J; Zhang JS; Qian CP; Hartmann L; Conover C; Jenkins R; Smith DI Oncogene; 1998 Feb; 16(5):635-42. PubMed ID: 9482109 [TBL] [Abstract][Full Text] [Related]
17. Frequent deletions of FHIT and FRA3B in Barrett's metaplasia and esophageal adenocarcinomas. Michael D; Beer DG; Wilke CW; Miller DE; Glover TW Oncogene; 1997 Oct; 15(14):1653-9. PubMed ID: 9349498 [TBL] [Abstract][Full Text] [Related]
18. Loss of FHIT expression in cervical carcinoma cell lines and primary tumors. Greenspan DL; Connolly DC; Wu R; Lei RY; Vogelstein JT; Kim YT; Mok JE; Muñoz N; Bosch FX; Shah K; Cho KR Cancer Res; 1997 Nov; 57(21):4692-8. PubMed ID: 9354423 [TBL] [Abstract][Full Text] [Related]
19. Evidence that instability within the FRA3B region extends four megabases. Becker NA; Thorland EC; Denison SR; Phillips LA; Smith DI Oncogene; 2002 Dec; 21(57):8713-22. PubMed ID: 12483524 [TBL] [Abstract][Full Text] [Related]